Because of the importance of the VEGF signalling pathway in angiogenesis, a focus on clinical therapy for human cancers, AMD, and DR and several other ocular neovascular diseases has been in development for inhibitors of VEGFR kinases to block the VEGF pathway. Here, KDR is linked to cancer.